Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Matrix metalloproteinase collagenolysis in health and disease.

Amar S, Smith L, Fields GB.

Biochim Biophys Acta. 2017 Nov;1864(11 Pt A):1940-1951. doi: 10.1016/j.bbamcr.2017.04.015. Epub 2017 Apr 26. Review.

PMID:
28456643
2.

Peripheral membrane associations of matrix metalloproteinases.

Van Doren SR, Marcink TC, Koppisetti RK, Jurkevich A, Fulcher YG.

Biochim Biophys Acta. 2017 Nov;1864(11 Pt A):1964-1973. doi: 10.1016/j.bbamcr.2017.04.013. Epub 2017 Apr 23. Review.

PMID:
28442379
3.

Biochemical and Biological Attributes of Matrix Metalloproteinases.

Cui N, Hu M, Khalil RA.

Prog Mol Biol Transl Sci. 2017;147:1-73. doi: 10.1016/bs.pmbts.2017.02.005. Epub 2017 Mar 22. Review.

PMID:
28413025
4.

Both Drosophila matrix metalloproteinases have released and membrane-tethered forms but have different substrates.

LaFever KS, Wang X, Page-McCaw P, Bhave G, Page-McCaw A.

Sci Rep. 2017 Mar 16;7:44560. doi: 10.1038/srep44560.

5.

Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.

Remacle AG, Cieplak P, Nam DH, Shiryaev SA, Ge X, Strongin AY.

Oncotarget. 2017 Jan 10;8(2):2781-2799. doi: 10.18632/oncotarget.13157.

6.

Matrix metalloproteinases as reagents for cell isolation.

Knapinska AM, Amar S, He Z, Matosevic S, Zylberberg C, Fields GB.

Enzyme Microb Technol. 2016 Nov;93-94:29-43. doi: 10.1016/j.enzmictec.2016.07.009. Epub 2016 Jul 20.

7.

Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7-H4) marks type 1 diabetes development.

Radichev IA, Maneva-Radicheva LV, Amatya C, Parker C, Ellefson J, Wasserfall C, Atkinson M, Burn P, Savinov AY.

Diabetes. 2014 Oct;63(10):3470-82. doi: 10.2337/db14-0213. Epub 2014 May 21.

8.

Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cells.

Remacle AG, Shiryaev SA, Golubkov VS, Freskos JN, Brown MA, Karwa AS, Naik AD, Howard CP, Sympson CJ, Strongin AY.

J Biol Chem. 2013 Jul 12;288(28):20568-80. doi: 10.1074/jbc.M113.471508. Epub 2013 Jun 3.

9.

Interstitial collagen catabolism.

Fields GB.

J Biol Chem. 2013 Mar 29;288(13):8785-93. doi: 10.1074/jbc.R113.451211. Epub 2013 Feb 19. Review.

10.
11.

Targeting metalloproteins by fragment-based lead discovery.

Johnson S, Barile E, Farina B, Purves A, Wei J, Chen LH, Shiryaev S, Zhang Z, Rodionova I, Agrawal A, Cohen SM, Osterman A, Strongin A, Pellecchia M.

Chem Biol Drug Des. 2011 Aug;78(2):211-23. doi: 10.1111/j.1747-0285.2011.01136.x. Epub 2011 Jun 16.

12.

Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.

Remacle AG, Shiryaev SA, Radichev IA, Rozanov DV, Stec B, Strongin AY.

J Biol Chem. 2011 Jun 10;286(23):21002-12. doi: 10.1074/jbc.M110.200139. Epub 2011 Apr 25.

13.

The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis.

Golubkov VS, Chekanov AV, Cieplak P, Aleshin AE, Chernov AV, Zhu W, Radichev IA, Zhang D, Dong PD, Strongin AY.

J Biol Chem. 2010 Nov 12;285(46):35740-9. doi: 10.1074/jbc.M110.165159. Epub 2010 Sep 13.

Supplemental Content

Support Center